These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1983374)

  • 21. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP; Schenk E; Tan G; Snel P; Nelis F
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The treatment of gastroesophageal reflux disease.
    Kaplan B; Koppelo KL
    W V Med J; 1994 Dec; 90(12):510-7. PubMed ID: 7863640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
    Armstrong D; Paré P; Pericak D; Pyzyk M;
    Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
    Bardhan KD; Cherian P; Jones RB; Vaishnavi A; Manek S; Bishop A; Polak J; Brooks A; Morris P; Thompson M; D'Silva J; Parkin S; Patterson J; Gillon KR
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton pump inhibitors in acute healing and maintenance of erosive or worse esophagitis: a systematic overview.
    Chiba N
    Can J Gastroenterol; 1997 Sep; 11 Suppl B():66B-73B. PubMed ID: 9347181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in the management of gastro-oesophageal reflux disease.
    Klinkenberg-Knol EC
    Scand J Gastroenterol Suppl; 1991; 188():101-7. PubMed ID: 1775934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Long-term results of conservative management of reflux esophagitis].
    Viani F; Dorta G
    Ther Umsch; 2001 Mar; 58(3):146-50. PubMed ID: 11305152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
    Harris RA; Kuppermann M; Richter JE
    Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole.
    Pace F; Annese V; Prada A; Zambelli A; Casalini S; Nardini P; Bianchi Porro G;
    Dig Liver Dis; 2005 Oct; 37(10):741-50. PubMed ID: 16024305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gastroesophageal reflux and esophagitis (II). Treatment guidelines].
    Velasco A; Alvarez FJ
    Rev Esp Enferm Dig; 1991 Jun; 79(6):416-23. PubMed ID: 1910920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Medical treatment of reflux peptic esophagitis: literature review].
    Van Gossum M
    Rev Med Brux; 1994; 15(1):20-4. PubMed ID: 7910701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic approaches to healing esophagitis.
    Boyce HW
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):22S-27S; discussion 27S-29S. PubMed ID: 9127623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of gastroesophageal reflux disease.
    Heidelbaugh JJ; Nostrant TT; Kim C; Van Harrison R
    Am Fam Physician; 2003 Oct; 68(7):1311-8. PubMed ID: 14567485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of gastroesophageal (acid) reflux with lansoprazole: an overview.
    Dobrilla G; Di Fede F
    Clin Ther; 1993; 15 Suppl B():2-13. PubMed ID: 7911400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Managing reflux in infants: lifestyle modifications or medications?
    Heiberger A
    S D Med; 2014 Jun; 67(6):237-8. PubMed ID: 24979984
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug therapy of reflux oesophagitis: an update.
    Tytgat GN
    Scand J Gastroenterol Suppl; 1989; 168():38-49. PubMed ID: 2575792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastroesophageal reflux disease in adults: pathophysiology, diagnosis, and management.
    Rex DK
    J Fam Pract; 1992 Dec; 35(6):673-81. PubMed ID: 1453152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis.
    Marks RD; Richter JE; Rizzo J; Koehler RE; Spenney JG; Mills TP; Champion G
    Gastroenterology; 1994 Apr; 106(4):907-15. PubMed ID: 7848395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acid reflux and gastro-oesophageal reflux disease.
    Watson AR; Bowling TE
    Br J Community Nurs; 2004 Aug; 9(8):326-30. PubMed ID: 15365470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.